News
Videos
Conferences
Events
Resources
Subscribe

Dr. Myung-Ju Ahn

Articles by Dr. Myung-Ju Ahn

Dr. Myung-Ju Ahn

Ifinatamab Deruxtecan Shows Activity in Previously Treated ES-SCLC

ByDr. Myung-Ju Ahn

September 8th 2025

Dr. Myung-Ju Ahn shared notable data on ifinatamab deruxtecan for patients with previously treated extensive-stage small cell lung cancer.

Latest Updated Articles

Ifinatamab Deruxtecan Shows Activity in Previously Treated ES-SCLC
Published: September 8th 2025 | Updated:

Trending on CURE

FDA Approves Revuforj for R/R NPM1-Mutant AML

How Does FDA-Approved Blenrep Treat Multiple Myeloma?

FDA Fast Tracks MT-125 for Glioblastoma

Finding Credible Voices in the Lynch Syndrome Community

Insights on Fertility and Survivorship in Hairy Cell Leukemia

© 2025 MJH Life Sciences^®

All rights reserved.